U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07066891) titled 'Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm' on June 07.
Brief Summary: The present study aims to conduct a prospective controlled trial comparing an LSTM-based artificial intelligence (AI) prediction model and clinicians' experience in the efficacy and safety of blood glucose control in hospitalized patients with type 2 diabetes mellitus (T2DM) receiving continuous subcutaneous insulin infusion (CSII) treatment in the Department of Endocrinology. The main question it aims to answer is:
Is the prediction model superior to or (at least) non-inferior to clinicians' experience?
Eligible pati...